SPOTLIGHT -
Slideshow
Author(s):
Three new studies on genetic risk factors and lifestyle; the transition from cognitive health to Alzheimer disease; and metabolic syndrome in depressed older adults.
April in Review: Updates on the Psychiatric Treatment Pipeline
Blue Light Blockers: A Behavior Therapy for Mania
Transneural Therapeutics: A New Company to Develop Novel Neuroplastogens
Blue Light, Depression, and Bipolar Disorder
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder
Investigating the SAINT iTBS Protocol for Bipolar I Depression